our products
our products

Call us at:



Click here to send us an email

Diagnostic Automation Question & AnswerDiagnostic Automation Question & Answer Diagnostic Automation Articles Diagnostic Automation videos

Epstein Barr Virus Early Antigen (EA) IgG ELISA kit


Epstein Barr Virus EA IgG ELISA Test

Full name

Human Epstein Barr Virus Early Antigen (EA) IgG ELISA Test Kit

Category Name Infectious Disease ELISA kits
Test 96
Method ELISA method: Enzyme Linked Immunosorbent Assay
Principle ELISA principle- Indirect; Antigen Coated Plate
Detection Range Qualitative elisa assay- Positive, Negative and Cut-off
Sample 10ul
Specificity 97%
Sensitivity 100%
Total Time ~60min
Shelf Life 12 Months from the manufacturing date

Item #:                    1415-P1   Quantity:               

Epstein Barr Virus Early Antigen (EA) IgG ELISA kit

EBV EA IgG 1415-11 (MSDS)(05-18-2016).pdf

Epstein Barr Virus Early Antigen (EA) IgG ELISA kit

callback phone number email us

Epstein Barr Virus Early Antigen (EA) IgG ELISA kit description:

Diagnostic Automation Epstein Barr Virus Early Antigen (EBV-EA) IgG Enzyme-linked Immunosorbent Assay (ELISA), is intended for the detection of IgG antibody to Epstein Barr Virus Nuclear Antigen-1 in human sera and plasma.

Materials Provided with EBV-EA IgG Elisa Kit:
1. Microwell strips: EBV-EA antigen coated wells
2. Sample Diluent
3. Calibrator
4. Negative control
5. Positive control
6. Washing concentrate 20x
7. Enzyme conjugate
8. TMB Chromogenic Substrate
9. Stop solution

Materials required but not provided:
1. Freshly distilled or deionized water
2. Dispensing system and/or pipette
3. EIA kit Microplate washer
4. EIA kit Microplate Reader with 450nm wavelength

EBV-EA IgG Elisa Test Background Information:
EBV is classified as a member of the herpes-virus family based upon its characteristic morphology. EBV infection may demonstrate a wide spectrum of clinical symptoms. The majority of primary EBV infections is transmitted via saliva, occurs during childhood, and is subclinical. Antibody titers to specific EBV antigens correlate with different stages of IM. Both IgM and IgG antibodies to the viral capsid antigen (VCA) peak 3 to 4 weeks after primary EBV infection. IgM anti-VCA declines rapidly and is usually undetectable after 12 weeks. IgG anti-VCA titers decline slowly after peaking but last indefinitely. Antibodies to EBV nuclear antigen (EBNA) detected by anti-complement immunofluorescence develop from 1 month to 6 months after infection; and, like anti-VCA, persist indefinitely. Antibodies to EBNA indicate that the EBV infection was not recent. Antibodies to EA may appear transiently for up to three months or longer during the acute phase of IM in 85% of patients. Elevated levels of anti-EA and IgG anti-VCA may be detected in patients with chronic or recurrent illness suspected of being caused by EBV. However, a diagnosis of chronic EBV should not be based on the presence of antibodies to EA since elevated anti-EA titers may also be found in patients with other diseases as well as in healthy individuals with past EBV infections.

EBV-EA IgG Elisa Test Principle:
Purified EBV-EA antigen is coated on the surface of microwells. Diluted patient serum is added to wells, the anti- EBV-EA specific antibody, if present, will bind to the antigen. All unbound materials are washed away. After adding enzyme conjugate, it binds to the antibody-antigen complex. Excess enzyme conjugate is washed off, and TMB Chromogenic substrate is added. The enzyme conjugate catalytic reaction is stopped at a specific time. The intensity of the color generated is proportional to the amount of specific antibody in the sample.

For more information about ELISA Kits, Rapid Tests, IFA Kits, CLIA Test Kits, or Serology tests, please see our website home page, or contact our Customer Service Representative at 818-591-3030.